Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

Journal of the American College of Surgeons

Volumn 221, Issue 3, 2015, Pages 717-728.e1

  Kremer, Michael ^a   Manzini, Giulia ^a   Hristov, Branimir ^a   Polychronidis, Georg ^a   Mokry, Theresa ^a   Sommer, Christoph M ^a   Mehrabi, Arianeb ^a   Weitz, Jürgen ^a   Büchler, Markus W ^a   Schemmer, Peter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ANEMIA; ARTICLE; ASCITES; ASSOCIATING LIVER PARTITION AND PORTAL VEIN LIGATION FOR STAGED HEPATECTOMY; BILE DUCT CARCINOMA; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; FUTURE LIVER REMNANT; GALLBLADDER CARCINOMA; HUMAN; LIVER HYPERTROPHY; LIVER RESECTION; MALE; OVERALL SURVIVAL; PARTIAL THROMBOPLASTIN TIME; PLEURA EFFUSION; PORTAL VEIN OBSTRUCTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; ROUX Y ANASTOMOSIS; SHORT TERM SURVIVAL; SURGICAL INFECTION; SURGICAL TECHNIQUE; VEIN LIGATION; WOUND DEHISCENCE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVERSE EFFECTS; AGED; DIGESTIVE SYSTEM NEOPLASMS; DRUG EFFECTS; LIGATION; LIVER; LIVER REGENERATION; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PORTAL VEIN; PROCEDURES; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIGATION; LIVER; LIVER REGENERATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGAN SIZE; PORTAL VEIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84939575568     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.05.017     Document Type: Article

References (59)

1. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
2. K. Tepetes, G. Christodoulidis, E.M. Spyridakis, and C. Chatzitheofilou Tissue preserving hepatectomy by a vessel sealing device J Surg Oncol 97 2008 165 168
3. A. Brouquet, and B. Nordlinger Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases Scand J Gastroenterol 47 2012 286 295
4. A. Andreou, A. Brouquet, E.K. Abdalla, and et al. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate HPB (Oxford) 13 2011 774 782
5. E.K. Abdalla Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome J Surg Oncol 102 2010 960 967
6. N.N. Rahbari, O.J. Garden, R. Padbury, and et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) Surgery 149 2011 713 724
7. F.J. Coimbra, T.C. Pires, W.L. Costa Junior, and et al. Advances in surgical treatment of colorectal liver metastases Rev Assoc Med Bras 57 2011 220 227
8. E.K. Abdalla, A. Denys, P. Chevalier, and et al. Total and segmental liver volume variations: implications for liver surgery Surgery 135 2004 404 410
9. E.J. Mullin, M.S. Metcalfe, and G.J. Maddern How much liver resection is too much? Am J Surg 190 2005 87 97
10. A. Abulkhir, P. Limongelli, A.J. Healey, and et al. Preoperative portal vein embolization for major liver resection: a meta-analysis Ann Surg 247 2008 49 57
11. T.M. van Gulik, J.W. van den Esschert, G.W. de, and et al. Controversies in the use of portal vein embolization Dig Surg 25 2008 436 444
12. A.A. Schnitzbauer, S.A. Lang, H. Goessmann, and et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings Ann Surg 255 2012 405 414
13. G. Morris-Stiff, Y.M. Tan, and J.N. Vauthey Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases Eur J Surg Oncol 34 2008 609 614
14. K. Ito, A. Govindarajan, H. Ito, and Y. Fong Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century Cancer J 16 2010 103 110
15. S. Mikalauskas, L. Mikalauskiene, H. Bruns, and et al. Dietary glycine protects from chemotherapy-induced hepatotoxicity Amino Acids 40 2011 1139 1150
16. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
17. M. Koch, O.J. Garden, R. Padbury, and et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery Surgery 149 2011 680 688
18. N.N. Rahbari, O.J. Garden, R. Padbury, and et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS) HPB (Oxford) 13 2011 528 535
19. N.N. Rahbari, M.N. Wente, P. Schemmer, and et al. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection Br J Surg 95 2008 424 432
20. Y. Morine, M. Shimada, and T. Utsunomiya Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis Hepatol Res 44 2014 59 69
21. C. Sturesson, I. Keussen, and K.G. Tranberg Prolonged chemotherapy impairs liver regeneration after portal vein occlusion - an audit of 26 patients Eur J Surg Oncol 36 2010 358 364
22. C. Sturesson, J. Nilsson, S. Eriksson, and et al. Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases HPB (Oxford) 15 2013 646 652
23. A.M. Covey, K.T. Brown, W.R. Jarnagin, and et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases Ann Surg 247 2008 451 455
24. D. Goere, O. Farges, J. Leporrier, and et al. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction J Gastrointest Surg 10 2006 365 370
25. J. Shindoh, C.W. Tzeng, T.A. Aloia, and et al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases Ann Surg Oncol 20 2013 2493 2500
26. J.N. Vauthey, A. Chaoui, K.A. Do, and et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations Surgery 127 2000 512 519
27. O. Farges, J. Belghiti, R. Kianmanesh, and et al. Portal vein embolization before right hepatectomy: prospective clinical trial Ann Surg 237 2003 208 217
28. D.C. Madoff, M.E. Hicks, E.K. Abdalla, and et al. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness-study in 26 patients Radiology 227 2003 251 260
29. S. Pandanaboyana, R. Bell, E. Hidalgo, and et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection Surgery 157 2015 690 698
30. N. Bellemann, U. Stampfl, C.M. Sommer, and et al. Portal vein embolization using a Histoacryl/Lipiodol mixture before right liver resection Dig Surg 29 2012 236 242
31. B. Bjornsson, T. Gasslander, and P. Sandstrom In situ split of the liver when portal venous embolization fails to induce hypertrophy: a report of two cases Case Rep Surg 2013 2013 238675
32. R. Hernandez-Alejandro, K.A. Bertens, K. Pineda-Solis, and K.P. Croome Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases? Surgery 157 2015 194 201
33. H. Liu, and S. Zhu Present status and future perspectives of preoperative portal vein embolization Am J Surg 197 2009 686 690
34. E. Schadde, V. Ardiles, K. Slankamenac, and et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis World J Surg 38 2014 1510 1519
35. J. Shindoh, C.W. Tzeng, T.A. Aloia, and et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients J Gastrointest Surg 18 2014 45 51
36. D.A. Wicherts, R.J. de Haas, P. Andreani, and et al. Short- and long-term results of extended left hepatectomy for colorectal metastases HPB (Oxford) 13 2011 536 543
37. T.C. Chua, W. Liauw, F. Chu, and D.L. Morris Summary outcomes of two-stage resection for advanced colorectal liver metastases J Surg Oncol 107 2013 211 216
38. V.W. Lam, J.M. Laurence, E. Johnston, and et al. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases HPB (Oxford) 15 2013 483 491
39. O.J. Torres, E.S. Fernandes, C.V. Oliveira, and et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): the Brazilian experience Arq Bras Cir Dig 26 2013 40 43
40. F.A. Alvarez, V. Ardiles, C.R. Sanchez, and et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks J Gastrointest Surg 17 2013 814 821
41. J. Li, P. Girotti, I. Konigsrainer, and et al. ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg 17 2013 956 961
42. K.J. Oldhafer, M. Donati, R.M. Jenner, and et al. ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence World J Surg 38 2014 1504 1509
43. W.T. Knoefel, I. Gabor, A. Rehders, and et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection Br J Surg 100 2013 388 394
44. S. Sala, V. Ardiles, M. Ulla, and et al. Our initial experience with ALPPS technique: encouraging results Updates Surg 64 2012 167 172
45. C.R. Robles, P.P. Paricio, A.L. Conesa, and et al. [A new surgical strategy for multiple multiple bilobular liver metastases: right portal occlusion and tourniquet in the parenchyma section line] Cir Esp 90 2012 191 196
46. E. Schadde, A.A. Schnitzbauer, C. Tschuor, and et al. Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy Ann Surg Oncol 2014 Dec 2 [Epub ahead of print]
47. K.P. Croome, R. Hernandez-Alejandro, M. Parker, and et al. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis HPB (Oxford) 17 2015 477 484
48. F.A. Alvarez, V. Ardiles, S.M. de, and et al. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center Ann Surg 261 2015 723 732
49. C.L. De, R. Sguinzi, C.R. De, and et al. Residual right portal branch flow after first-step ALPPS: artifact or homeostatic response? Hepatogastroenterology 61 2014 1712 1716
50. B. Aussilhou, S. Dokmak, S. Faivre, and et al. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab Ann Surg Oncol 16 2009 1553 1559
51. A. Rickenbacher, M.L. DeOliveira, Y. Tian, and et al. Arguments against toxic effects of chemotherapy on liver injury and regeneration in an experimental model of partial hepatectomy Liver Int 31 2011 313 321
52. N. Kokudo, and J. Shindoh How can we safely climb the ALPPS? Updates Surg 65 2013 175 177
53. D.A. Wicherts, R. Miller, R.J. de Haas, and et al. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases Ann Surg 248 2008 994 1005
54. J. Shindoh, C.W. Tzeng, T.A. Aloia, and et al. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival Br J Surg 100 2013 1777 1783
55. L. Xiao, J.W. Li, and S.G. Zheng Totally laparoscopic ALPPS in the treatment of cirrhotic hepatocellular carcinoma Surg Endosc 2014 Dec 17 [Epub ahead of print]
56. S. Hayashi, Y. Baba, K. Ueno, and et al. Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization Acta Radiol 48 2007 721 727
57. L.T. Hoekstra, K.P. van Lienden, A. Doets, and et al. Tumor progression after preoperative portal vein embolization Ann Surg 256 2012 812 817
58. L.C. Ye, T.S. Liu, L. Ren, and et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases J Clin Oncol 31 2013 1931 1938
59. K.B. Groot, and Y. Fong Outcomes in biliary malignancy J Surg Oncol 110 2014 585 591